The in-vitro activity of a new semi-synthetic streptogramin compound, RP 59500, against staphylococci and respiratory pathogens.
Andrews
J M
JM
Department of Medical Microbiology, Dudley Road Hospital, Birmingham, UK.
Wise
R
R
D000693:Anaerobiosis; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D001419:Bacteria / Q000187:drug effects*; D003470:Culture Media; D008826:Microbial Sensitivity Tests; D012141:Respiratory Tract Infections / Q000382:microbiology*; D013210:Staphylococcus / Q000187:drug effects*; D014769:Virginiamycin / Q000494:pharmacology*
D000900:Anti-Bacterial Agents; D003470:Culture Media; D014769:Virginiamycin; C062940:quinupristin-dalfopristin